TCTMD

Directions Website

TCTMD Your source for breaking news, topical videos, and slides covering cardiovascular disease and interv

TCTMD is the most comprehensive on-line resource in interventional cardiology and provides indepth coverage of the percutaneous treatment of cardiovascular disease. Since its launch at TCT 2000, TCTMD has provided clinicians and industry professionals myriad ways to keep up-to-date in the ever-evolving field, including news and data from conferences hosted around the world as well as information about the latest devices and drugs used in the daily practice of cardiovascular medicine.

09/15/2026

Task force members emphasize the STAMP method: Screen, Triage, Address risk, Modify management, and Plan services.

09/14/2026

HF with mildly reduced EF is gone, stages are updated, and new classifications for medical and interventional therapies are introduced.

09/14/2026

Investigators stressed that the method is simple, doesn’t require ultrasound, and can be done with existing cath lab infrastructure.

09/14/2026

What challenges will AI pose for medical education going forward? Thomas Lüscher shares the mistakes algorithms can make, as well as how they can challenge physicians to better prioritize empathy in patient care. Watch here: https://bit.ly/3T4wihN

09/11/2026

The latest UDMI aims to align classifications with pathology and clinical practice, bringing numerous changes to the 2018 version.

09/11/2026

The data “give you pause” when considering closure, especially for women who can tolerate DOACs, Christine Albert says.

09/11/2026

Asymptomatic patients will now be covered and more flexibility has been given to heart teams for individualizing patient care.

09/10/2026

Martin Leon speaks to two experts in the valve community, Philippe Pibarot and Ajit Yoganathan, about how we can better understand bioprosthetic valve performance and durability in order to improve long-term care. Listen to the full episode for more insights: https://bit.ly/4xnFGLR

09/10/2026

SHASTA-3/4 trial data show plozasiran, like olezarsen, can drastically lower triglycerides and the risk of acute pancreatitis.

Address

1700 Broadway
New York, NY
10019

Website

Alerts

Be the first to know and let us send you an email when TCTMD posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Sponsored

Share

Category